CompletedNot Applicable

Gold Factor on Knee Joint Health and Function

United States51 participantsStarted 2020-08-03

Plain-language summary

The purpose of this clinical study was to determine whether gold nanoparticles (AuNP) supplement holds clinical value in improving joint health, function, and quality of life for arthritis patients.

Who can participate

Age range18 Years – 87 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥ 18 and \<87 years of age * Having arthritis * Suffering from chronic knee pain * Failed treatments to date - including surgery, Physical Therapy, NSAIDs * Must agree to maintain the same eating, exercise, and sleep arrangements for the whole duration of the study Exclusion Criteria: * Having bacterial, intra-articular, or knee infections * Had any knee related partial or complete total knee replacement within 3 months prior to the start of the study * Had recent (3 months prior to start of the study) knee injection * Currently on NSAIDs * currently pregnant or lactating

What they're measuring

Knee injury and Osteoarthritis Outcome Score (KOOS): Pain score

Timeframe: 20 weeks

Knee injury and Osteoarthritis Outcome Score (KOOS): Symptoms score

Timeframe: 20 weeks

Knee injury and Osteoarthritis Outcome Score (KOOS): Function in Activities of Daily Living (ADL) score

Timeframe: 20 weeks

Knee injury and Osteoarthritis Outcome Score (KOOS): Function in Sports and Recreation score

Timeframe: 20 weeks

Knee injury and Osteoarthritis Outcome Score (KOOS): Quality of Life score

Timeframe: 20 weeks

C-Reactive Protein

Timeframe: 20 weeks

Range of Motion Bilateral Flexion score

Timeframe: 20 weeks

Leg Press repetition number

Timeframe: 20 weeks

Trial details

NCT IDNCT05347602

Sponsor4Life Research, LLC

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2020-12-30

View on ClinicalTrials.gov More Knee Arthritis trials